Jeff Green is the primary architect for Ingenuity Pathway Analysis (IPA) and leads a cross-functional team at QIAGEN to apply machine learning to curated content.
AI & Data Science Showcase:
QIAGEN Digital Insights
QIAGEN Digital Insights was established in 2014, based on the acquisitions of Ingenuity, CLC bio, and BIOBASE. Today, the three legacy companies are joined by OmicSoft and N-of-One, working closely together to help our users innovate, integrate and translate basic discoveries into clinical care.
Leveraging Latent Knowledge To Accelerate Drug Discovery
The application of unsupervised embedding techniques to structured, curated scientific content is a powerful way to discover latent knowledge. We use this machine learning approach to infer new disease-gene associations and interpret gene expression data to create actionable hypotheses.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.